JP2006502250A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502250A5
JP2006502250A5 JP2004525225A JP2004525225A JP2006502250A5 JP 2006502250 A5 JP2006502250 A5 JP 2006502250A5 JP 2004525225 A JP2004525225 A JP 2004525225A JP 2004525225 A JP2004525225 A JP 2004525225A JP 2006502250 A5 JP2006502250 A5 JP 2006502250A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004525225A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502250A (ja
JP4451308B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/007736 external-priority patent/WO2004012773A1/en
Publication of JP2006502250A publication Critical patent/JP2006502250A/ja
Publication of JP2006502250A5 publication Critical patent/JP2006502250A5/ja
Application granted granted Critical
Publication of JP4451308B2 publication Critical patent/JP4451308B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004525225A 2002-07-24 2003-07-16 ポリアルキレングリコール酸添加剤 Expired - Fee Related JP4451308B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39813702P 2002-07-24 2002-07-24
PCT/EP2003/007736 WO2004012773A1 (en) 2002-07-24 2003-07-16 Polyalkylene glycol acid additives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008182692A Division JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Publications (3)

Publication Number Publication Date
JP2006502250A JP2006502250A (ja) 2006-01-19
JP2006502250A5 true JP2006502250A5 (enExample) 2008-09-04
JP4451308B2 JP4451308B2 (ja) 2010-04-14

Family

ID=31495718

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004525225A Expired - Fee Related JP4451308B2 (ja) 2002-07-24 2003-07-16 ポリアルキレングリコール酸添加剤
JP2008182692A Expired - Fee Related JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008182692A Expired - Fee Related JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Country Status (13)

Country Link
US (2) US7193031B2 (enExample)
EP (1) EP1526872A1 (enExample)
JP (2) JP4451308B2 (enExample)
KR (1) KR100608415B1 (enExample)
CN (1) CN100337689C (enExample)
AR (1) AR040654A1 (enExample)
AU (1) AU2003258518B2 (enExample)
BR (1) BR0313212A (enExample)
CA (1) CA2492775C (enExample)
MX (1) MXPA05000796A (enExample)
PL (1) PL375265A1 (enExample)
RU (1) RU2318004C2 (enExample)
WO (1) WO2004012773A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
ES2528254T3 (es) 2002-06-07 2015-02-05 Dyax Corp. Polipéptidos de dominio Kunitz modificado y su uso para reducir la isquemia o el inicio de una respuesta inflamatoria sistémica asociada con un procedimiento quirúrgico
BR0313212A (pt) * 2002-07-24 2005-06-28 Hoffmann La Roche Aditivos de ácido de polialquileno glicol
US20050089515A1 (en) * 2003-08-29 2005-04-28 Dyax Corp. Poly-pegylated protease inhibitors
EP1663279A4 (en) * 2003-08-29 2009-02-18 Dyax Corp MODIFIED PROTEASE INHIBITORS
CA2558583C (en) * 2004-03-15 2013-07-09 Nektar Therapeutics Al, Corporation Polymer-based compositions and conjugates of hiv entry inhibitors
WO2005111116A1 (en) * 2004-05-17 2005-11-24 Mcmaster University Biological molecule-reactive hydrophilic silicone surface
CA2573262C (en) * 2004-07-16 2015-02-10 Nektar Therapeutics Al, Corporation Conjugates of a gm-csf moiety and a polymer
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
JP5021649B2 (ja) * 2005-08-26 2012-09-12 ノヴォ ノルディスク アクティーゼルスカブ 高分子システムを変性する方法
US8133707B2 (en) * 2006-01-17 2012-03-13 Enzon Pharmaceuticals, Inc. Methods of preparing activated polymers having alpha nitrogen groups
CL2008002054A1 (es) 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
AR067537A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
AU2008289005A1 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
KR101671537B1 (ko) * 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
EP2385843A4 (en) 2009-01-06 2013-02-27 Dyax Corp TREATMENT OF MUZOSITIS WITH CALLICINE INHIBITORS
HRP20220107T1 (hr) 2010-01-06 2022-04-15 Takeda Pharmaceutical Company Limited Proteini koji vežu kalikrein plazme
US10040761B2 (en) * 2010-06-25 2018-08-07 Nof Corporation Branched hetero polyethylene glycol and intermediate
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
CN105713092B (zh) 2011-01-06 2019-09-10 戴埃克斯有限公司 血浆前激肽释放酶结合蛋白
CN104411807B (zh) * 2012-04-03 2018-10-02 桑加特公司 琥珀酰亚胺活化型硝酰化合物及其用于蛋白质硝酰化的使用方法
CN102816227A (zh) * 2012-08-30 2012-12-12 深圳赛保尔生物药业有限公司 回收促红细胞生成素的方法
CN105188761B (zh) 2013-03-15 2020-05-15 桑加特公司 聚环氧烷戊酸酯血红蛋白缀合物
IL247942B (en) 2014-03-27 2022-09-01 Dyax Corp Compositions and methods for drops in macular edema as a result of diabetes
KR20250139401A (ko) 2015-12-11 2025-09-23 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 저해제 및 유전성 혈관부종 발작을 치료하기 위한 이의 용도
JP7376850B2 (ja) * 2019-03-29 2023-11-09 日油株式会社 末端カルボキシル基含有ポリエチレングリコールの製造方法および活性化ポリエチレングリコールの製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849450B2 (ja) 1975-07-09 1983-11-04 株式会社日立製作所 スイリヨクシキカプセルユソウソウチノ ボウシクホウ
DE3675588D1 (de) * 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
JP2531661B2 (ja) 1987-02-25 1996-09-04 味の素株式会社 酸素運搬剤
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
HUT75533A (en) * 1993-11-10 1997-05-28 Schering Corp Improved interferon polymer conjugates
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
DE69735292T2 (de) * 1996-10-25 2006-10-19 Gilead Sciences, Inc., Foster City Gefaesszellen wachstumsfaktor (vegf) nukleinsäureligand-komplexe
DE60004172T2 (de) 1999-01-29 2004-04-22 F. Hoffmann-La Roche Ag Gcsf konjugate
PE20001548A1 (es) 1999-03-02 2001-01-16 Schering Corp Uso de interferon alfa pegilado para el tratamiento de vih-1
CZ299516B6 (cs) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
HU228491B1 (en) 1999-10-08 2013-03-28 Nektar Therapeutics Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
KR100653153B1 (ko) * 1999-12-22 2006-12-01 넥타르 테라퓨틱스 에이엘, 코포레이션 수용성 중합체의 입체장애 유도체
US20020065397A1 (en) 2000-10-12 2002-05-30 Joseph Roberts Protecting therapeutic compositions from host-mediated inactivation
DE60144439D1 (de) * 2000-12-20 2011-05-26 Hoffmann La Roche Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
BR0313212A (pt) * 2002-07-24 2005-06-28 Hoffmann La Roche Aditivos de ácido de polialquileno glicol

Similar Documents

Publication Publication Date Title
JP2006502250A5 (enExample)
JP2007515381A5 (enExample)
JP2006028409A5 (enExample)
JP2005247844A5 (enExample)
JP2007063520A5 (enExample)
JP2006503960A5 (enExample)
JP2006514019A5 (enExample)
JP2004244619A5 (enExample)
JP2006188651A5 (enExample)
JP2004168997A5 (enExample)
JP2003305787A5 (enExample)
JP2005533836A5 (enExample)
JP2008514623A5 (enExample)
JP2006028280A5 (enExample)
JP2006510481A5 (enExample)
JP2005523387A5 (enExample)
JP2004262980A5 (enExample)
JP2007070320A5 (enExample)
JP2005206527A5 (enExample)
JP2005035984A5 (enExample)
JP2005506321A5 (enExample)
JP2005002267A5 (enExample)
JP2004294750A5 (enExample)
JP2006233098A5 (enExample)
JP2005503339A5 (enExample)